This announcement is a separate document:
康希諾生物-B：(1) 建議採納激勵計劃及建議根據特別授權發行限制性股票；(2) 建議採納考覈管理辦法；(3) 建議授權董事會處理激勵計劃相關事項；及(4) 2021年第二次臨時股東大會通告及2021年第一次H股類別股東大會通告
CANSINOBIO-B: (1) PROPOSED ADOPTION OF THE INCENTIVE SCHEME AND PROPOSED ISSUE OF RESTRICTED SHARES PURSUANT TO SPECIFIC MANDATE; (2) PROPOSED ADOPTION OF THE MANAGEMENT MEASURES FOR ASSESSMENT; (3) PROPOSED AUTHORIZATION TO THE BOARD OF DIRECTORS TO DEAL
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.